Sns Financial Group, LLC Eli Lilly & CO Call Options Transaction History

Sns Financial Group, LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $116,976 - $135,304	-800 Reduced 8.25%	8,900 $1.32 Million
Q1 2020 May 07, 2020	SELL	$119.05 - $147.35 $130,955 - $162,085	-1,100 Reduced 10.19%	9,700 $1.35 Million
Q4 2019 Feb 07, 2020	BUY	$106.92 - $132.43 $1.15 Million - $1.43 Million	10,800 New	10,800 $1.42 Million

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $749B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Sns Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Sns Financial Group, LLC with notifications on news.